Showing results (311-320 of 555) with videos related to
Sort By:
Pageof 56
JAMA Dermatology|May 12, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Andreas Wollenberg, et al.The British Journal of Dermatology|January 18, 2022
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trialsGil Yosipovitch, Kim Papp, Seth Forman, et al.Annals of Clinical and Laboratory Science|February 10, 2009
IgE anti-varicella zoster virus and other immune responses before, during, and after shinglesTamar A Smith-Norowitz, Joby Josekutty, Hadar Lev-Tov, et al.The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2018
Health Utility Scores of Atopic Dermatitis in US AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Atopic Dermatitis in US Adults: From Population to Health Care UtilizationJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.International Journal of Biomedical Science : IJBS|May 16, 2013
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus VaccineTamar A Smith-Norowitz, Joby Josekutty, Jonathan I Silverberg, et al.Journal of the American Academy of Dermatology|February 10, 2024
Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a studyJonathan I Silverberg, Robert S Kirsner, David J Margolis, et al.Journal of Drugs in Dermatology : JDD|October 6, 2023
Selection of Nemolizumab Clinical Dosage for Atopic DermatitisNathalie Wagner, Luca Loprete, Vincent Duval, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2022
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7Jonathan I Silverberg, Eric L Simpson, Jacob Pontoppidan Thyssen, et al.Journal of Drugs in Dermatology : JDD|October 7, 2020
Clinical Relevance of Skin Pain in Atopic DermatitisSonja Ständer, Eric L Simpson, Emma Guttman-Yassky, et al.Pageof 56